Colorectal Cancer Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Prevalence of Colorectal Cancer Globally
- Growth in Efficient Treatment Options
Challenges
- Expensive Colorectal Cancer Treatment Therapies
- Lack of Awareness About the Disease in Lower Economic Regions
Colorectal Cancer Treatment Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.2% |
|
Base Year Market Size (2024) |
USD 20.08 billion |
|
Forecast Year Market Size (2037) |
USD 34.28 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of colorectal cancer treatment is assessed at USD 20.8 billion.
Colorectal Cancer Treatment Market size was valued at USD 20.08 billion in 2024 and is expected to reach USD 34.28 billion by 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is estimated to account for largest revenue share by 2037, owing to increasing awareness about colorectal cancer and need to develop innovative cancer treatment solutions in the region.
The major players in the market are Genentech, Inc., Eli Lilly and Company, F. Hoffman-La Roche AG, and Bristol Myers Squibb, among others.
